Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity

Journal of Cell Biology

Volumn 134, Issue 3, 1996, Pages 757-770

  Morris, Erick J ^a   Geller, Herbert M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; DNA DAMAGE; DNA SYNTHESIS; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0029738086     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.134.3.757     Document Type: Article

References (73)

1. Basma, A.N., E.J. Morris, W.J. Nicklas, and H.M. Geller. 1995. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64:825-832.
2. Batistatou, A., and L.A. Greene. 1991. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol. 115:461-471.
3. Bendixen, C., B. Thomsen, J. Alsner, and O. Westergaard. 1990. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry. 29:5613-5619.
4. Bertrand, R., E. Solary, J. Jenkins, and Y. Pommier. 1993. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp. Cell Res. 207:388-397.
5. Bruno, S., P. Lassota, W. Giaretti, and Z. Darzynkiewicz. 1992. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases. Oncol. Res. 4:29-35.
6. Chatterjee, S., M.F. Cheng, D. Trivedi, S.J. Petzold, and N.A. Berger. 1989. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun. 1:389-394.
7. Chen, A.Y., and L.F. Liu. 1994. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191-218.
8. Chodosh, L.A., A. Fire, M. Samuels, and P.A. Sharp. 1989. 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264:2250-2257.
9. Chopp, M., P.H. Chan, Y.H. Chung, M.E. Cheung, and T.P. Jacobs. 1996. DNA damage and repair in central nervous system injury. National Institute of Neurological Disorders and Stroke Workshop Summary. Stroke. 27:363-369.
10. Clarke, D.W., F.T. Boyd, Jr., M.S. Kappy, and M.K. Raizada. 1985. Insulin stimulates macromolecular synthesis in cultured glial cells from rat brain. Am. J. Physiol. 249:C484-489.
11. Cohen, J.J., R.C. Duke, V.A. Fadok, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267-293.
12. Cotter, T.G., J.M. Glynn, F. Echeverri, and D.R. Green. 1992. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:773-780.
13. D'Arpa, P. 1994. Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugs. In DNA Topoisomerases: Topoisomerase Targeting Drugs. L.F. Liu, editor. Academic Press, San Diego. 12-143.
14. D'Arpa, P., C. Beardmore, and L.F. Liu. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50:6919-6924.
15. D'Mello, S.R., C. Galli, T. Ciotti, and P. Calissano. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA. 90: 10989-10993.
16. Deckwerth, T.L., and E.M. Johnson, Jr. 1993. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123:1207-1222.
17. Deleted in proof.
18. Del Bino, G., S. Bruno, P.N. Yi, and Z. Darzynkiewicz. 1992. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif. 25:537-548.
19. Dessi, F., H. Pollard, J. Moreau, Y. Ben-Ari, and C. Charriaut-Marlangue. 1995. Cytosine arabinoside induces apoptosis in cerebellar neurons in culture. J. Neurochem. 64:1980-1987.
20. Dubrez, L., F. Goldwasser, P. Genne, Y. Pommier, and E. Solary. 1995. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia. 9:1013-1024.
21. Dwyer, B.E., R.N. Nishimura, and S.Y. Lu. 1995. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody - response to oxidative stress. Mol. Brain Res. 30:37-47.
22. Eng, W.K., L. Faucette, R.K. Johnson, and R. Sternglanz. 1988. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34:755-760.
23. Flangas, A.L., and R.E. Bowman. 1970. Differential metabolism of RNA in neuronal-enriched and glial-enriched fractions of rat cerebrum. J. Neurochem. 17:1237-1245.
24. Deleted in proof.
25. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945-1951.
26. Hartley, A., J.M. Stone, C. Heron, J.M. Cooper, and A.H. Schapira. 1994. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63:1987-1990.
27. Hickson, I.D., S.L. Davies, S.M. Davies, and C.N. Robson. 1990. DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. Int. J. Rad. Biol. 58:561-568.
28. Hsiang, Y.H., R. Hertzberg, S. Hecht, and L.F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878.
29. Hsiang, Y.H., M.G. Lihou, and L.F. Liu. 1989. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077-5082.
30. Hwang, J., and C.L. Hwong. 1994. Cellular regulation of mammalian DNA topoisomerases. In DNA Topoisomerases: Biochemistry and Molecular Biology. L.F. Liu, editor. Academic Press, San Diego. 167-189.
31. Johnson, E.M., Jr., and T.L. Deckwerth. 1993. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci 16:31-46.
32. Kessel, D. 1971. Effects of camptothecin on RNA synthesis in leukemia L1210 cells. Biochim. Biophys. Acta. 246:225-232.
33. Koh, J.Y., M.B. Wie, B.J. Gwag, S.L. Sensi, L.M.T. Canzoniero, J. Demaro, C. Csernansky, and D.W. Choi. 1995. Staurosporine-induced neuronal apoptosis. Exp. Neurol. 135:153-159.
34. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond). 227:680-685.
35. Leadon, S.A., and P.K. Cooper. 1993. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne syndrome. Proc. Natl. Acad. Sci. USA. 90:10499-10503.
36. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74: 957-967.
37. Madden, K.R., and J.J. Champoux. 1992. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res. 52:525-532.
38. Martin, D.P., R.E. Schmidt, P.S. DiStefano, O.H. Lowry, J.G. Carter, and E.M. Johnson, Jr. 1988. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106:829-844.
39. Mizuguchi, M., K. Ikeda, M. Asada, S. Mizutani, and S. Kamoshita. 1994. Expression of Bcl-2 protein in murine neural cells in culture. Brain Res. 649:197-202.
40. Morrison, R.S., and J. deVellis. 1981. Growth of purified astrocytes in a chemically defined medium. Proc. Natl. Acad. Sci. USA. 78:7205-7209.
41. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
42. Muller, M.T., W.P. Pfund, V.B. Mehta, and D.K. Trask. 1985. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO (Eur. Mol. Biol. Organ.) J. 4:1237-1243.
43. Nakajima, M., K. Kashiwagi, J. Ohta, S. Furukawa, K. Hayashi, T. Kawashima, and Y. Hayashi. 1994. Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system. Brain Res. 641:350-352.
44. Nakajima, M., K. Kashiwagi, J. Ohta, S. Furukawa, K. Hayashi, T. Kawashima, and Y. Hayashi. 1994. Nerve growth factor and epidermal growth factor rescue PC12 cells from programmed cell death induced by etoposide: distinct modes of protection against cell death by growth factors and a protein-synthesis inhibitor. Neurosci. Lett. 176:161-164.
45. Nitiss, J., and J.C. Wang. 1988. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA. 85:7501-7505.
46. O'Connor, P.M., D. Kerrigan, R. Bertrand, K.W. Kohn, and Y. Pommier. 1990. 10,11-methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells. Cancer Commun. 2:395-400.
47. Oppenheim, R.W. 1991. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501.
48. Perego, P., G. Capranico, R. Supino, and F. Zunino. 1994. Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types. Anti-Cancer Drugs. 5:645-649.
49. Perry, R.P., and D.E. Kelley. 1970. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J. Cell Physiol. 76:127-139.
50. Petroski, R.E., and H.M. Geller. 1994. Selective labeling of embryonic neurons cultured on astrocyte monolayers with 5(6)-carboxyfluorescein diacetate (CFDA). J. Neurosci. Methods. 52:23-32.
51. Pommier, Y., A. Tanizawa, and K.W. Kohn. 1994. Mechanisms of topoisomerase I inhibition by anticancer drugs. In DNA Topoisomerases: Topoisomerase-targeting Drugs. L.F. Liu, editor. Academic Press, San Diego. 73-93.
52. Ratan, R.R., T.H. Murphy, and J.M. Baraban. 1994. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:376-379.
53. Sarkander, H.I., and H.J. Dulce. 1978. Studies on the regulation of RNA synthesis in neuronal and glial nuclei isolated from rat brain. Exp. Brain Res. 31:317-327.
54. Soffer, D., H.W. Grotsky, I. Rapin, and K. Suzuki. 1979. Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann. Neurol. 6:340-348.
55. Solary, E., R. Bertrand, K.W. Kohn, and Y. Pommier. 1993. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 5:1359-1368.
56. Squires, S., A.J. Ryan, H.L. Strutt, and R.T. Johnson. 1993. Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. Cancer Res. 53:2012-2019.
57. 2+ ionophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res. 652:65-70.
58. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science (Wash. DC). 267:1456-1462.
59. Tishler, R.B., S.K. Calderwood, C.N. Coleman, and B.D. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:2212-2216.
60. Tomkins, C.E., S.N. Edwards, and A.M. Tolkovsky. 1994. Apoptosis is induced in post-mitotic rat sympathetic neurons by arabinosides and topoisomerase II inhibitors in the presence of NGF. J. Cell Sci 107:1499-1507.
61. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
62. Venema, J., L.H.F. Mullenders, A.T. Natarajan, A.A. van Zeeland, and L.V. Mayne. 1990. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. Natl. Acad. Sci. USA. 87:4707-4711.
63. Ventimiglia, R., and H.M. Geller. 1987. Cell types and cell-substrate interactions in serum-free dissociated cultures of rat hypothalamus. Brain Res. 436:339-351.
64. Vogel, H., and D.S. Horoupian. 1993. Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity. Cancer. 71:1303-1308.
65. Wall, M.E., M.C. Wani, C.E. Cook, K.H. Palmer, A.T. McPhail, and G.A. Sim. 1966. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 83:3888-3890.
66. Walton, M.I., D. Whysong, P.M. O'Connor, D. Hockenberry, S.J. Korsmeyer, and K.W. Kohn. 1993. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res. 53:1853-1861.
67. Wang, J.C. 1985. DNA topoisomerases. Annu. Rev. Biochem. 54:665-697.
68. Waser, J., U. Hubscher, C.C. Kuenzle, and S. Spadari. 1979. DNA polymerase beta from brain neurons is a repair enzyme. Eur. J. Biochem. 97: 361-368.
69. Winkelman, M.D., and J.D. Hines. 1983. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann. Neurol. 14:520-527.
70. Wood, K.A., and R.J. Youle. 1995. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15:5851-5857.
71. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.). 284:555-556.
72. Wyllie, A.H., R.G. Morris, A.L. Smith, and D. Dunlop. 1984. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142:67-77.
73. Zhang, H., J.C. Wang, and L.F. Liu. 1988. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA. 85:1060-1064.